Vivani Medical Inc. (VANI) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.19 (-1.65%), Market cap $0.10B, 52-week low–high $0.94 ~ $1.87.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who ar
Financial statements, price targets, institutional (13F) holdings and related news for Vivani Medical Inc. are updated in real time on BlackAll Trade.
Vivani Medical Inc. trades at $1.19 (-1.65%). Real-time quotes and charts are available on BlackAll Trade.
Vivani Medical Inc. has a market cap of about $0.10B.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal im